March

ERJ Podcast Eur Respir J 2014; 43: E39
The “other” COPD Han MeiLan K. Eur Respir J 2014; 43: 659-661
Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities Aaron Shawn D. Eur Respir J 2014; 43: 662-664
Monitoring disease progression in COPD patients: one step beyond! Burgel Pierre-Régis Eur Respir J 2014; 43: 665-667
Systemic steroids in severe forms of COPD exacerbations: a question of balance? Similowski Thomas, Suissa Samy Eur Respir J 2014; 43: 668-670
Protocadherin-1: epithelial barrier dysfunction in asthma and eczema Faura Tellez Grissel, Nawijn Martijn C., Koppelman Gerard H. Eur Respir J 2014; 43: 671-674
Increased daily activity in cystic fibrosis: time to break out the prescription pad? Fitzgerald Dominic A. Eur Respir J 2014; 43: 675-677
Paediatric tuberculosis in Europe: lessons from Denmark and inclusive strategies to consider Marais Ben J., Tadolini Marina, Zignol Matteo, Migliori Giovanni Battista Eur Respir J 2014; 43: 678-684
Inflammation in pulmonary arterial hypertension: is it time to quell the fire? Hassoun Paul M. Eur Respir J 2014; 43: 685-688
Prediction of chronic lung allograft dysfunction: a systems medicine challenge Pison Christophe, Magnan Antoine, Botturi Karine, Sève Michel, Brouard Sophie, Marsland Benjamin J., Ernst Florian, Paprotka Tobias, Deplanche Kevin, Fritz Andreas, Siroux Valérie, Boissel Jean-Pierre, Corris Paul A., Auffray Charles, Nicod Laurent P. Eur Respir J 2014; 43: 689-693
Asthma and pulmonary embolism: bringing airways and vessels closer together Konstantinides Stavros V. Eur Respir J 2014; 43: 694-696
The tuberculosis time bomb: taking control of the TB threat in Europe El-Nemr Tanja Eur Respir J 2014; 43: 697-699
From the Museum: the Art of Thinking Kotsimbos Tom Eur Respir J 2014; 43: 700-701
From the Museum: the Art of Thinking. Part One: Thinking Kotsimbos Tom Eur Respir J 2014; 43: 702-703
Perinatal outcomes following maternal asthma and cigarette smoking during pregnancy Hodyl Nicolette A., Stark Michael J., Scheil Wendy, Grzeskowiak Luke E., Clifton Vicki L. Eur Respir J 2014; 43: 704-716
Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation Abroug Fekri, Ouanes-Besbes Lamia, Fkih-Hassen Mohamed, Ouanes Islem, Ayed Samia, Dachraoui Fahmi, Brochard Laurent, ElAtrous Souheil Eur Respir J 2014; 43: 717-724
COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women Camp Pat G., Ramirez-Venegas Alejandra, Sansores Raul H., Alva Luis F., McDougall Jill E., Sin Don D., Paré Peter D., Müller Nestor L., Silva C. Isabela S., Rojas Carlos E., Coxson Harvey O. Eur Respir J 2014; 43: 725-734
Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT) Mackay Alex J., Donaldson Gavin C., Patel Anant R.C., Singh Richa, Kowlessar Beverly, Wedzicha Jadwiga A. Eur Respir J 2014; 43: 735-744
Longitudinal assessment in COPD patients: multidimensional variability and outcomes Casanova Ciro, Aguirre-Jaíme Armando, de Torres Juan P., Pinto-Plata Victor, Baz Rebeca, Marin Jose M., Divo Miguel, Cordoba Elizabeth, Basaldua Santiago, Cote Claudia, Celli Bartolomé R. Eur Respir J 2014; 43: 745-753
Variability of hospital resources for acute care of COPD patients: the European COPD Audit López-Campos Jose Luis, Hartl Sylvia, Pozo-Rodriguez Francisco, Roberts C. Michael Eur Respir J 2014; 43: 754-762
A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD Agustí Alvar, de Teresa Luis, De Backer Wilfried, Zvarich Michael T., Locantore Nicholas, Barnes Neil, Bourbeau Jean, Crim Courtney Eur Respir J 2014; 43: 763-772
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma O’Byrne Paul M., Bleecker Eugene R., Bateman Eric D., Busse William W., Woodcock Ashley, Forth Richard, Toler William T., Jacques Loretta, Lötvall Jan Eur Respir J 2014; 43: 773-782
It’s the adherence, stupid (that determines asthma control in preschool children)! Klok Ted, Kaptein Adrian A., Duiverman Eric J., Brand Paul L. Eur Respir J 2014; 43: 783-791
The PCDH1 gene and asthma in early childhood Mortensen Li J., Kreiner-Møller Eskil, Hakonarson Hakon, Bønnelykke Klaus, Bisgaard Hans Eur Respir J 2014; 43: 792-800
Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study Chung Wei-Sheng, Lin Cheng-Li, Ho Feng-Ming, Li Ruei-Yuan, Sung Fung-Chang, Kao Chia-Hung, Yeh Jun-Jun Eur Respir J 2014; 43: 801-807
Impaired lung function and health status in adult survivors of bronchopulmonary dysplasia Gough Aisling, Linden Mark, Spence Dale, Patterson Chris C., Halliday Henry L., McGarvey Lorcan P.A. Eur Respir J 2014; 43: 808-816
Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis Schneiderman Jane E., Wilkes Donna L., Atenafu Eshetu G., Nguyen Thanh, Wells Greg D., Alarie Nancy, Tullis Elizabeth, Lands Larry C., Coates Allan L., Corey Mary, Ratjen Felix Eur Respir J 2014; 43: 817-823
Neighbourhood air quality and snoring in school-aged children Kheirandish-Gozal Leila, Ghalebandi Mirfarhad, Salehi Mansour, Salarifar Mohammad Hosein, Gozal David Eur Respir J 2014; 43: 824-832
Pneumococcal disease seasonality: incidence, severity and the role of influenza activity Weinberger Daniel M., Harboe Zitta B., Viboud Cécile, Krause Tyra G., Miller Mark, Mølbak Kåre, Konradsen Helle B. Eur Respir J 2014; 43: 833-841
Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data Salih Waleed, Schembri Stuart, Chalmers James D. Eur Respir J 2014; 43: 842-851
IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia Lim Hui Fang, Phua Jason, Mukhopadhyay Amartya, Ngerng Wang Jee, Chew Mei Ying, Sim Tiong Beng, Kuan Win Sen, Mahadevan Malcolm, Lim Tow Keang Eur Respir J 2014; 43: 852-862
A review of paediatric tuberculosis in Denmark: 10-year trend, 2000–2009 Hatleberg Camilla Ingrid, Prahl Julie B., Rasmussen Jeppe Nørgaard, Andersen Peter Henrik, Bjerrum Stephanie, Thomsen Vibeke Østergaard, Johansen Isik Somuncu Eur Respir J 2014; 43: 863-871
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype Warth Arne, Penzel Roland, Lindenmaier Heike, Brandt Regine, Stenzinger Albrecht, Herpel Esther, Goeppert Benjamin, Thomas Michael, Herth Felix J.F., Dienemann Hendrik, Schnabel Philipp A., Schirmacher Peter, Hoffmann Hans, Muley Thomas, Weichert Wilko Eur Respir J 2014; 43: 872-883
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis Alsaad Noor, Wilffert Bob, van Altena Richard, de Lange Wiel C.M., van der Werf Tjip S., Kosterink Jos G.W., Alffenaar Jan-Willem C. Eur Respir J 2014; 43: 884-897
Impact of symptoms of anxiety and depression on COPD Assessment Test scores Hilmarsen Christina W., Wilke Sarah, Engan Harald, Spruit Martijn A., Rodenburg Johan, Janssen Daisy J.A., Steinshamn Sigurd, Jones Paul W., Wouters Emiel F.M., Oldervoll Line, Franssen Frits M.E. Eur Respir J 2014; 43: 898-900
Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis De Soyza Anthony, Perry Audrey, Hall Amanda J., Sunny Syba S., Walton Kathy E., Mustafa Nazim, Turton Jane, Kenna Dervla T., Winstanley Craig Eur Respir J 2014; 43: 900-903
Rapidly progressing tuberculosis outbreak in a very low risk group Coitinho Cecilia, Greif Gonzalo, Robello Carlos, Laserra Paula, Willery Eve, Supply Philip Eur Respir J 2014; 43: 903-906
Severe pulmonary embolism decreases plasma l-arginine Kline Jeffrey A., Watts John, Courtney Daniel, Lee Yong Yook, Hwang Sunil Eur Respir J 2014; 43: 906-909
Prediction of outcome after PEA in chronic thromboembolic pulmonary hypertension using indexed pulmonary artery diameter Schölzel Bastiaan E., Post Martijn C., Dymarkowski Steven, Wuyts Wim, Meyns Bart, Budts Werner, Morshuis Wim, Snijder Repke J., Delcroix Marion Eur Respir J 2014; 43: 909-912
Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension Heresi Gustavo A., Aytekin Metin, Hammel Jeffrey P., Wang Sihe, Chatterjee Soumya, Dweik Raed A. Eur Respir J 2014; 43: 912-914
Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension Cracowski Jean-Luc, Chabot François, Labarère José, Faure Patrice, Degano Bruno, Schwebel Carole, Chaouat Ari, Reynaud-Gaubert Martine, Cracowski Claire, Sitbon Olivier, Yaici Azzedine, Simonneau Gerald, Humbert Marc Eur Respir J 2014; 43: 915-917
Patient selection before endobronchial valve treatment Yang Zhen, Chen Jie, Chen Liang An Eur Respir J 2014; 43: 918-919
Infant lung function and wheeze in later childhood in the Southampton Women’s Survey Brooke Emily, Lucas Jane S.A., Collins Samuel A., Holloway John W., Roberts Graham, Inskip Hazel, Godfrey Keith M., Cooper Cyrus, Pike Katharine C., the Southampton Women’s Survey Study Group Eur Respir J 2014; 43: 919-921
Infant lung function and wheeze in later childhood in the Southampton Women’s Survey van der Gugten Anne C., van der Ent Cornelis K., Uiterwaal Cuno S.P.M. Eur Respir J 2014; 43: 921-922
Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID Kollert Florian, Venhoff Nils, Goldacker Sigune, Wehr Claudia, Lützen Niklas, Voll Reinhard E., Prasse Antje, Warnatz Klaus Eur Respir J 2014; 43: 922-924
Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID Naccache Jean-Marc, Bouvry Diane, Valeyre Dominique Eur Respir J 2014; 43: 924-925